-
Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies
Market news
PharmaSources.comSeptember 26, 2021
Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced a strategic investment in Nirrin Technologies...
-
LINK Medical Expands its Regulatory Services Team, Strengthening its IMPD & CMC Capabilities
Market news
PharmaSourcesMay 06, 2021
LINK Medical expands its regulatory services team, strengthening its IMPD & CMC capabilities.
-
New Progress in the Hair Loss Prevention Drug Market: JAK Inhibitor Baricitinib Reaches Phase 3 Clinical Primary Endpoint
Market news
PharmaSources.comMarch 26, 2021
Eli Lilly and Company and Incyte jointly announced on Mar. 3, 2021 that baricitinib, an oral JAK inhibitor, met its primary endpoint in Phase 3 clinical trial for the treatment of adult patients with severe alopecia areata (AA).
-
Da-pag-li-flo-zin is Well Tolerated in Hospitalized Patients
Market news
firstwordpharmaJune 28, 2021
DARE-19 is the first large randomized clinical trial to assess sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with and without type 2 diabetes hospitalized with COVID-19.
-
Qilian International Holding Group Limited Completes Phase One of Its Expansion of New Organic Fertilizer Production Facility and Puts It into Production
Market news
prnasiaOctober 27, 2021
Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced that the Company...
-
Introducing Prodigy for Improved Peptide Purification
Market news
prnasiaOctober 27, 2021
CEM Corporation is proud to announce the release of the new Prodigy™ Preparative High-Performance Liquid Chromatography (HPLC) system. Key to the system is its unique elevated temperature capability...
-
Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines
Market news
prnasiaOctober 27, 2021
Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be included in the World Health Organisation (WHO) Solidarity Trial Vaccines (STv).
-
API supply chain needs to address future challenges arising from China situation: CPhI Worldwide panel
Market news
CPhIonlineOctober 27, 2021
The COVID-19 pandemic has exposed weaknesses in the complex supply chain for active pharmaceutical ingredients (APIs) and the sector needs to address the challenges of rising production costs in China...
-
Chinese mainland reports 29 locally transmitted COVID-19 cases
Market news
NMPAOctober 27, 2021
BEIJING -- The Chinese mainland on Monday reported 29 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Tuesday.
-
Vaccination of young children begins around country
Market news
NMPAOctober 27, 2021
Many provinces in China have started vaccinating children aged 3 to 11, as the number of COVID-19 cases has grown due to small recent outbreaks related to tour groups in Gansu province...
Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced a strategic investment in Nirrin Technologies...
LINK Medical expands its regulatory services team, strengthening its IMPD & CMC capabilities.
Eli Lilly and Company and Incyte jointly announced on Mar. 3, 2021 that baricitinib, an oral JAK inhibitor, met its primary endpoint in Phase 3 clinical trial for the treatment of adult patients with severe alopecia areata (AA).
DARE-19 is the first large randomized clinical trial to assess sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with and without type 2 diabetes hospitalized with COVID-19.
Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced that the Company...
CEM Corporation is proud to announce the release of the new Prodigy™ Preparative High-Performance Liquid Chromatography (HPLC) system. Key to the system is its unique elevated temperature capability...
Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be included in the World Health Organisation (WHO) Solidarity Trial Vaccines (STv).
The COVID-19 pandemic has exposed weaknesses in the complex supply chain for active pharmaceutical ingredients (APIs) and the sector needs to address the challenges of rising production costs in China...
BEIJING -- The Chinese mainland on Monday reported 29 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Tuesday.
Many provinces in China have started vaccinating children aged 3 to 11, as the number of COVID-19 cases has grown due to small recent outbreaks related to tour groups in Gansu province...
Pharma Sources Insight 08/2021
